• About us
• Contact

Advertisement

Organisation › Details

Danaher (Group)

Danaher (NYSE:DHR), based in Washington. D.C., is a diversified technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. Our portfolio of premier brands is among the most highly recognized in each of the markets we serve. Driven by the Danaher Business System, our 50,000 associates serve customers in more than 125 countries and generated $12.7 billion of revenue in 2008. *

 

	Start	2002-05-06 existent
	Industry	analytical instrument
	Industry 2	diagnostics (medical/biological)
	Person	Blair, Rainer M. (Danaher 2022 CEO before EVP Life Sciences + Head Life Sciences + AB Sciex + Videojet + MAPEI + BASF)
	Region	Washington, D.C.
	Country	United States (USA)
	Street	2099 Pennsylvania Avenue, NW
	City	20006 Washington, DC
	Tel	+1-202-828-0850
		Address record changed: 2020-12-02
Basic data	Employees	J: more than 100,0 (2021-12-31)
	Currency	USD
	Annual sales	29,453,000,000 (sales, consolidated (2021) 2021-12-31)
	Profit	6,433,000,000 (2021-12-31)
	Cash	2,586,000,000 (2021-12-31)
		* Document for »About Section«:
		Record changed: 2023-07-10

Advertisement

More documents for Danaher (Group)

• [1] CrestOptics S.p.A.. (10/7/24). "Press Release: CrestOptics and Leica Microsystems Announce Strategic Collaboration to Expand Capabilities of Spinning Disk Microscopy". Rome....
• [2] Genedata AG. (9/5/24). "Press Release: Immunocore Selects Genedata to Scale Up Discovery of Novel TCR Therapeutics". Basel....
• [3] Eppendorf SE. (8/30/24). "Press Release: Dr. Christine Munz Becomes CEO at Eppendorf". Hamburg....
• [4] Genedata AG. (8/19/24). "Press Release: Genedata Joins Danaher Corporation". Basel....
• [5] Molecular Health GmbH. (5/15/24). "Press Release: Integrated DNA Technologies and Molecular Health Ink Commercial Partnership". Coralville, IA & Heidelberg....
• [6] Danaher Corporation. (10/31/23). "Press Release: Danaher Appoints Christopher Riley to Executive Vice President for Biotechnology". Washington D.C.....
• [7] Danaher Corporation. (8/28/23). "Press Release: Danaher to Acquire Abcam". Washington, DC....
• [8] Abcam plc. (6/23/23). "Press Release: Abcam Announces Review of Strategic Alternatives". Cambridge & Waltham, MA....
• [9] Molecular Devices, LLC. (2/7/23). "Press Release: Molecular Devices Partners with Seed Biosciences to Exclusively Offer DispenCell Single-Cell Dispenser, Expanding Leadership in Cell Line Development". San José, CA....
• [10] Refeyn Ltd.. (1/23/23). "Press Release: Refeyn Appoints Interim CEO"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.